XML
105
R33.htm
IDEA: XBRL DOCUMENT

v3.25.0.1

FAIR VALUE (Tables)

12 Months Ended

Dec. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Valuation of Investments and Other Financial Instruments by Fair Value Hierarchy Levels
The following tables summarize the financial assets and financial liabilities measured at fair value for the Company and the Consolidated Funds as of December 31, 2024:

Financial Instruments of the Company Level I Level II Level III Investments Measured at NAV Total
Assets, at fair value

Cash equivalents:

Money market funds $ 1,071,071 $ $ $ $ 1,071,071
Investments:

Common stock and other equity securities 104,037 411,179 515,216
Collateralized loan obligations and fixed income securities
 41,833 41,833
Partnership interests 238 238
Total investments, at fair value 104,037 453,012 238 557,287
Derivatives-foreign currency forward contracts 3,737 3,737
Total assets, at fair value $ 1,071,071 $ 107,774 $ 453,012 $ 238 $ 1,632,095
Liabilities, at fair value
Derivatives-foreign currency forward contracts $ $ (216) $ $ $ (216)
Contingent consideration (17,550) (17,550)
Total liabilities, at fair value $ $ (216) $ (17,550) $ $ (17,766)

Financial Instruments of the Consolidated Funds Level I Level II Level III Investments Measured at NAV Total
Assets, at fair value
Investments:
Fixed income investments:
Loans and securitization vehicles $ $ 7,313,632 $ 593,817 $ $ 7,907,449
U.S. treasury securities 550,800 550,800
Bonds 418,069 418,069

Total fixed income investments 550,800 7,731,701 593,817 8,876,318
Partnership interests 2,000,380 2,000,380
Equity securities 28,603 2,615 1,829,928 1,861,146
Total investments, at fair value 579,403 7,734,316 2,423,745 2,000,380 12,737,844

Derivatives-foreign currency forward contracts 2,995 2,995

Total assets, at fair value $ 579,403 $ 7,737,311 $ 2,423,745 $ 2,000,380 $ 12,740,839
Liabilities, at fair value
Loan obligations of CLOs $ $ (9,672,189) $ $ $ (9,672,189)
Derivatives:

Foreign currency forward contracts (2,888) (2,888)
Asset swaps (1,846) (1,846)

Total derivative liabilities, at fair value (2,888) (1,846) (4,734)
Total liabilities, at fair value $ $ (9,675,077) $ (1,846) $ $ (9,676,923)

The following tables summarize the financial assets and financial liabilities measured at fair value for the Company and the Consolidated Funds as of December 31, 2023:

Financial Instruments of the Company Level I Level II Level III Investments Measured at NAV Total
Assets, at fair value

Investments:

Common stock and other equity securities $ $ 86,572 $ 412,491 $ $ 499,063
Collateralized loan obligations and fixed income securities
 126,294 126,294
Partnership interests 6,287 6,287
Total investments, at fair value 86,572 538,785 6,287 631,644
Derivatives-foreign currency forward contracts 1,129 1,129
Total assets, at fair value $ $ 87,701 $ 538,785 $ 6,287 $ 632,773
Liabilities, at fair value
Derivatives-foreign currency forward contracts $ $ (2,645) $ $ $ (2,645)

Total liabilities, at fair value $ $ (2,645) $ $ $ (2,645)

Financial Instruments of the Consolidated Funds Level I Level II Level III Investments Measured at NAV Total
Assets, at fair value
Investments:
Fixed income investments:
Loans and securitization vehicles $ $ 9,879,915 $ 736,543 $ $ 10,616,458
Bonds 575,379 3,570 578,949
U.S. treasury securities 523,038 523,038
Total fixed income investments 523,038 10,455,294 740,113 11,718,445
Partnership interests 1,642,489 1,642,489
Equity securities 47,503 2,750 1,190,400 1,240,653
Total investments, at fair value 570,541 10,458,044 1,930,513 1,642,489 14,601,587

Derivatives-foreign currency forward contracts 9,126 9,126

Total assets, at fair value $ 570,541 $ 10,467,170 $ 1,930,513 $ 1,642,489 $ 14,610,713
Liabilities, at fair value
Loan obligations of CLOs $ $ (12,345,657) $ $ $ (12,345,657)
Derivatives:

Foreign currency forward contracts (9,491) (9,491)
Asset swaps (1,291) (1,291)
Total derivative liabilities, at fair value (9,491) (1,291) (10,782)
Total liabilities, at fair value $ $ (12,355,148) $ (1,291) $ $ (12,356,439)

Schedule of Changes in the Fair Value of the Level III Investments, Liabilities
The following tables set forth a summary of changes in the fair value of the Level III measurements:

Level III Assets of the Company Equity Securities Fixed Income Contingent Consideration Total
Balance as of December 31, 2023
 $ 412,491 $ 126,294 $ $ 538,785

Established in connection with acquisition (see Note 8)
 (17,550) (17,550)
Transfer in(1)
 39,636 39,636
Transfer out(1)
 (872) (872)
Purchases(2)
 1,453 436,649 438,102
Sales/settlements(3)
 (2,382) (561,492) (563,874)

Realized and unrealized appreciation, net 489 746 1,235
Balance as of December 31, 2024
 $ 411,179 $ 41,833 $ (17,550) $ 435,462
Change in net unrealized appreciation/depreciation included in earnings related to financial assets still held at the reporting date $ (904) $ 2,172 $ $ 1,268

Level III Net Assets of Consolidated Funds Equity Securities Fixed Income Derivatives, Net Total
Balance as of December 31, 2023 $ 1,190,400 $ 740,113 $ (1,291) $ 1,929,222

Transfer in(1)
 87,505 87,505
Transfer out(1)
 (1,017) (154,961) (155,978)
Purchases(2)
 518,369 877,311 130 1,395,810
Sales/settlements(3)
 (114) (960,839) (960,953)

Realized and unrealized appreciation (depreciation), net 122,289 4,688 (685) 126,292
Balance as of December 31, 2024 $ 1,829,927 $ 593,817 $ (1,846) $ 2,421,898
Change in net unrealized appreciation/depreciation included in earnings related to financial assets and liabilities still held at the reporting date $ 123,659 $ 2,237 $ (744) $ 125,152

(1)Transfers in and out include changes in the observability of inputs used in valuations, and changes due to the consolidation and deconsolidation of funds.
(2)Purchases include paid-in-kind interest and securities received in connection with restructurings.
(3)Sales/settlements include distributions, principal redemptions and securities disposed of in connection with restructurings.

Level III Assets of the Company Equity Securities Fixed Income Total
Balance as of December 31, 2022
 $ 121,785 $ 76,934 $ 198,719

Purchases(1)
 244,335 88,480 332,815
Sales/settlements(2)
 (2) (37,332) (37,334)

Realized and unrealized appreciation (depreciation), net 46,373 (1,788) 44,585
Balance as of December 31, 2023
 $ 412,491 $ 126,294 $ 538,785
Change in net unrealized appreciation/depreciation included in earnings related to financial assets still held at the reporting date $ 46,161 $ (1,577) $ 44,584

Level III Net Assets of Consolidated Funds Equity Securities Fixed Income Partnership Interests Derivatives, Net Total
Balance as of December 31, 2022 $ 730,880 $ 869,668 $ 368,655 $ (3,556) $ 1,965,647

Transfer in(3)
 247,661 247,661
Transfer out(3)
 (38,757) (508,600) (374,049) (921,406)
Purchases(1)
 347,583 813,564 49,000 1,210,147
Sales/settlements(2)
 (2,595) (700,944) (48,889) (154) (752,582)

Realized and unrealized appreciation, net 153,289 18,764 5,283 2,419 179,755
Balance as of December 31, 2023 $ 1,190,400 $ 740,113 $ $ (1,291) $ 1,929,222
Change in net unrealized appreciation/depreciation included in earnings related to financial assets and liabilities still held at the reporting date $ 152,336 $ (15,623) $ $ 1,590 $ 138,303

(1)Purchases include paid-in-kind interest and securities received in connection with restructurings.
(2)Sales/settlements include distributions, principal redemptions and securities disposed of in connection with restructurings.
(3)Transfers in and out include changes in the observability of inputs used in valuations, and changes due to the consolidation and deconsolidation of funds.

Schedule of Quantitative Inputs and Assumptions used for Level III Inputs
The following tables summarize the quantitative inputs and assumptions used for the Company s and the Consolidated Funds Level III measurements as of December 31, 2024:

Level III Measurements of the Company Fair Value Valuation Technique(s) Significant Unobservable Input(s) Range Weighted Average
Assets
Equity securities
 $ 168,387 Transaction price(1)
 N/A N/A N/A
 100,000 Market approach Yield 8.0%
 8.0%

 57,659 Market approach Multiple of book value 1.0x - 1.1x
 1.0x

 Discounted cash flow Discount rate 10.0% - 14.0%
 12.0%

 56,918 Market approach Multiple of book value 1.2x - 1.7x
 1.4x

 19,205 Option pricing model Volatility 35.0% 35.0%
 8,489 Market approach Earnings multiple
 15.4x
 15.4x

 521 Discounted cash flow Discount rate 18.5% - 21.5%
 20.0%
Fixed income investments
 22,283 Transaction price(1)
 N/A N/A
 N/A
 19,040 Broker quotes and/or 3rd party pricing services N/A N/A N/A
 510 Other N/A N/A N/A
Total assets $ 453,012
Liabilities
Contingent consideration $ (17,550) Monte Carlo simulation Discount rate 6.6% - 6.9%
 6.8%
 Volatility 11.1% 11.1%
Total liabilities $ (17,550)

Level III Measurements of the Consolidated Funds Fair Value Valuation Technique(s) Significant Unobservable Input(s) Range Weighted Average
Assets
Equity securities
 $ 985,109 Discounted cash flow Discount rate 10.0% - 20.0%
 13.0%
 835,432 Market approach Multiple of book value 1.0x - 1.7x
 1.4x

 8,598 Market approach EBITDA multiple(2)
 5.6x - 34.6x
 10.7x

 789 Other N/A N/A N/A

Fixed income investments
 308,675 Broker quotes and/or 3rd party pricing services N/A N/A N/A
 284,950 Market approach Yield 7.4% - 28.6%
 9.9%

 192 Other N/A N/A N/A

Total assets $ 2,423,745
Liabilities
Derivative instruments $ (1,846) Broker quotes and/or 3rd party pricing services N/A N/A N/A
Total liabilities $ (1,846)

(1)Transaction price consists of securities purchased or restructured. The Company determined that there was no change to the valuation based on the underlying assumptions used at the closing of such transactions.
(2) EBITDA in the table above is a non-GAAP financial measure and refers to earnings before interest, tax, depreciation and amortization.

The following tables summarize the quantitative inputs and assumptions used for the Company s and the Consolidated Funds Level III measurements as of December 31, 2023:

Level III Measurements of the Company Fair Value Valuation Technique(s) Significant Unobservable Input(s) Range Weighted Average
Assets
Equity securities
 $ 154,460 Discounted cash flow Discount rate 20.0% - 30.0%
 25.0%
 118,846 Market approach Multiple of book value 1.3x - 1.6x
 1.5x

 131,864 Transaction price(1)
 N/A N/A N/A
 6,447 Market approach Earnings multiple 15.4x
 15.4x

 874 Other N/A N/A N/A

Fixed income investments
 83,000 Transaction price(1)
 N/A N/A N/A
 20,799 Broker quotes and/or 3rd party pricing services N/A N/A N/A
 22,495 Other N/A N/A N/A
Total assets $ 538,785

Level III Measurements of the Consolidated Funds Fair Value Valuation Technique(s) Significant Unobservable Input(s) Range Weighted Average
Assets
Equity securities
 $ 648,581 Discounted cash flow Discount rate 10.0% - 16.0%
 13.0%

 537,733 Market approach Multiple of book value 1.0x - 1.7x
 1.3x

 3,909 Market approach EBITDA multiple(2)
 4.5x - 32.4x
 8.9x

 177 Other N/A N/A N/A

Fixed income investments
 548,264 Broker quotes and/or 3rd party pricing services N/A N/A N/A
 188,322 Market approach Yield 8.3% - 24.1%
 12.2%

 2,974 Market approach EBITDA multiple(2)
 4.5x - 32.4x
 9.0x

 104 Discounted cash flow Discount rate 12.3%
 12.3%

 449 Other N/A N/A N/A

Total assets $ 1,930,513
Liabilities
Derivative instruments $ (1,291) Broker quotes and/or 3rd party pricing services N/A N/A N/A
Total liabilities $ (1,291)

(1)Transaction price consists of securities purchased or restructured. The Company determined that there has been no change to the valuation based on the underlying assumptions used at the closing of such transactions.
(2) EBITDA in the table above is a non-GAAP financial measure and refers to earnings before interest, tax, depreciation and amortization.

Schedule of Investments and Unfunded Commitments Valued Using NAV per Share
The following table summarizes the investments held at fair value and unfunded commitments of the Consolidated Funds interests valued using NAV per share:

 As of December 31,
 2024 2023

Investments (held at fair value) $ 2,000,380 $ 1,642,489
Unfunded commitments 932,473 738,621

X

- DefinitionTabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity.

+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef
 -Topic 820
 -SubTopic 10
 -Name Accounting Standards Codification
 -Section 50
 -Paragraph 2
 -Subparagraph (b)
 -Publisher FASB
 -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
 -Topic 820
 -SubTopic 10
 -Name Accounting Standards Codification
 -Section 50
 -Paragraph 2
 -Subparagraph (a)
 -Publisher FASB
 -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 3: http://www.xbrl.org/2003/role/exampleRef
 -Topic 820
 -SubTopic 10
 -Name Accounting Standards Codification
 -Section 55
 -Paragraph 100
 -Publisher FASB
 -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
 -Topic 820
 -SubTopic 10
 -Name Accounting Standards Codification
 -Section 50
 -Paragraph 3
 -Subparagraph (a)
 -Publisher FASB
 -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3

+ Details

 Name:
us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock

 Namespace Prefix:
us-gaap_

 Data Type:
dtr-types:textBlockItemType

 Balance Type:
na

 Period Type:
duration

X

- DefinitionTabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.

+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef
 -Topic 820
 -SubTopic 10
 -Name Accounting Standards Codification
 -Section 55
 -Paragraph 103
 -Publisher FASB
 -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
 -Topic 820
 -SubTopic 10
 -Name Accounting Standards Codification
 -Section 50
 -Paragraph 2
 -Subparagraph (bbb)(2)
 -Publisher FASB
 -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
 -Topic 820
 -SubTopic 10
 -Name Accounting Standards Codification
 -Section 50
 -Paragraph 2
 -Subparagraph (bbb)(1)
 -Publisher FASB
 -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

+ Details

 Name:
us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock

 Namespace Prefix:
us-gaap_

 Data Type:
dtr-types:textBlockItemType

 Balance Type:
na

 Period Type:
duration

X

- ReferencesNo definition available.

+ Details

 Name:
us-gaap_FairValueDisclosuresAbstract

 Namespace Prefix:
us-gaap_

 Data Type:
xbrli:stringItemType

 Balance Type:
na

 Period Type:
duration

X

- DefinitionTabular disclosure of investments in certain entities that calculate net asset value per share or equivalent measured at fair value on a recurring or nonrecurring basis.

+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef
 -Topic 820
 -SubTopic 10
 -Name Accounting Standards Codification
 -Section 55
 -Paragraph 107
 -Publisher FASB
 -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
 -Topic 820
 -SubTopic 10
 -Name Accounting Standards Codification
 -Section 35
 -Paragraph 54B
 -Publisher FASB
 -URI https://asc.fasb.org/1943274/2147482134/820-10-35-54B

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
 -Topic 820
 -SubTopic 10
 -Name Accounting Standards Codification
 -Section 50
 -Paragraph 8
 -Publisher FASB
 -URI https://asc.fasb.org/1943274/2147482106/820-10-50-8

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
 -Topic 820
 -SubTopic 10
 -Name Accounting Standards Codification
 -Section 50
 -Paragraph 6A
 -Publisher FASB
 -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A

+ Details

 Name:
us-gaap_FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareTableTextBlock

 Namespace Prefix:
us-gaap_

 Data Type:
dtr-types:textBlockItemType

 Balance Type:
na

 Period Type:
duration

X

- DefinitionTabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.

+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef
 -Topic 820
 -SubTopic 10
 -Name Accounting Standards Codification
 -Section 50
 -Paragraph 3
 -Subparagraph (b)
 -Publisher FASB
 -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
 -Topic 820
 -SubTopic 10
 -Name Accounting Standards Codification
 -Section 50
 -Paragraph 2
 -Subparagraph (d)
 -Publisher FASB
 -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
 -Topic 820
 -SubTopic 10
 -Name Accounting Standards Codification
 -Section 50
 -Paragraph 2
 -Subparagraph (c)
 -Publisher FASB
 -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

+ Details

 Name:
us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock

 Namespace Prefix:
us-gaap_

 Data Type:
dtr-types:textBlockItemType

 Balance Type:
na

 Period Type:
duration